001     177539
005     20240229133742.0
024 7 _ |a 10.1161/JAHA.120.019814
|2 doi
024 7 _ |a pmid:34796724
|2 pmid
024 7 _ |a altmetric:117224868
|2 altmetric
037 _ _ |a DKFZ-2021-02606
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Steur, Marinka
|0 0000-0002-9028-0290
|b 0
245 _ _ |a Dietary Fatty Acids, Macronutrient Substitutions, Food Sources and Incidence of Coronary Heart Disease: Findings From the EPIC-CVD Case-Cohort Study Across Nine European Countries.
260 _ _ |a New York, NY
|c 2021
|b Association
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1642512665_14848
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a 2021 Dec 7;10(23):e019814
520 _ _ |a Background There is controversy about associations between total dietary fatty acids, their classes (saturated fatty acids [SFAs], monounsaturated fatty acids, and polyunsaturated fatty acids), and risk of coronary heart disease (CHD). Specifically, the relevance of food sources of SFAs to CHD associations is uncertain. Methods and Results We conducted a case-cohort study involving 10 529 incident CHD cases and a random subcohort of 16 730 adults selected from a cohort of 385 747 participants in 9 countries of the EPIC (European Prospective Investigation into Cancer and Nutrition) study. We estimated multivariable adjusted country-specific hazard ratios (HRs) and 95% CIs per 5% of energy intake from dietary fatty acids, with and without isocaloric macronutrient substitutions, using Prentice-weighted Cox regression models and pooled results using random-effects meta-analysis. We found no evidence for associations of the consumption of total or fatty acid classes with CHD, regardless of macronutrient substitutions. In analyses considering food sources, CHD incidence was lower per 1% higher energy intake of SFAs from yogurt (HR, 0.93 [95% CI, 0.88-0.99]), cheese (HR, 0.98 [95% CI, 0.96-1.00]), and fish (HR, 0.87 [95% CI, 0.75-1.00]), but higher for SFAs from red meat (HR, 1.07 [95% CI, 1.02-1.12]) and butter (HR, 1.02 [95% CI, 1.00-1.04]). Conclusions This observational study found no strong associations of total fatty acids, SFAs, monounsaturated fatty acids, and polyunsaturated fatty acids, with incident CHD. By contrast, we found associations of SFAs with CHD in opposite directions dependent on the food source. These findings should be further confirmed, but support public health recommendations to consider food sources alongside the macronutrients they contain, and suggest the importance of the overall food matrix.
536 _ _ |a 313 - Krebsrisikofaktoren und Prävention (POF4-313)
|0 G:(DE-HGF)POF4-313
|c POF4-313
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo01.inet.dkfz-heidelberg.de
650 _ 7 |a coronary heart disease
|2 Other
650 _ 7 |a dietary guidelines
|2 Other
650 _ 7 |a nutritional epidemiology
|2 Other
650 _ 7 |a primary prevention
|2 Other
650 _ 7 |a saturated fat
|2 Other
700 1 _ |a Johnson, Laura
|b 1
700 1 _ |a Sharp, Stephen J
|b 2
700 1 _ |a Imamura, Fumiaki
|0 0000-0002-6841-8396
|b 3
700 1 _ |a Sluijs, Ivonne
|b 4
700 1 _ |a Key, Timothy J
|0 0000-0003-2294-307X
|b 5
700 1 _ |a Wood, Angela
|b 6
700 1 _ |a Chowdhury, Rajiv
|0 0000-0003-4881-5690
|b 7
700 1 _ |a Guevara, Marcela
|0 0000-0001-9242-6364
|b 8
700 1 _ |a Jakobsen, Marianne U
|0 0000-0001-6518-4136
|b 9
700 1 _ |a Johansson, Ingegerd
|0 0000-0002-9227-8434
|b 10
700 1 _ |a Koulman, Albert
|b 11
700 1 _ |a Overvad, Kim
|b 12
700 1 _ |a Sánchez, Maria-José
|b 13
700 1 _ |a van der Schouw, Yvonne T
|b 14
700 1 _ |a Trichopoulou, Antonia
|b 15
700 1 _ |a Weiderpass, Elisabete
|0 0000-0003-2237-0128
|b 16
700 1 _ |a Wennberg, Maria
|b 17
700 1 _ |a Zheng, Ju-Sheng
|b 18
700 1 _ |a Boeing, Heiner
|b 19
700 1 _ |a Boer, Jolanda M A
|0 0000-0002-9714-4304
|b 20
700 1 _ |a Boutron-Ruault, Marie-Christine
|0 0000-0002-5956-5693
|b 21
700 1 _ |a Ericson, Ulrika
|b 22
700 1 _ |a Heath, Alicia K
|0 0000-0001-6517-1300
|b 23
700 1 _ |a Huybrechts, Inge
|0 0000-0003-3838-855X
|b 24
700 1 _ |a Imaz, Liher
|0 0000-0002-3777-4953
|b 25
700 1 _ |a Kaaks, Rudolf
|0 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
|b 26
|u dkfz
700 1 _ |a Krogh, Vittorio
|b 27
700 1 _ |a Kühn, Tilman
|b 28
700 1 _ |a Kyrø, Cecilie
|b 29
700 1 _ |a Masala, Giovanna
|0 0000-0002-5758-9069
|b 30
700 1 _ |a Melander, Olle
|b 31
700 1 _ |a Moreno-Iribas, Conchi
|b 32
700 1 _ |a Panico, Salvatore
|b 33
700 1 _ |a Quirós, José R
|b 34
700 1 _ |a Rodríguez-Barranco, Miguel
|b 35
700 1 _ |a Sacerdote, Carlotta
|b 36
700 1 _ |a Santiuste, Carmen
|b 37
700 1 _ |a Skeie, Guri
|b 38
700 1 _ |a Tjønneland, Anne
|b 39
700 1 _ |a Tumino, Rosario
|b 40
700 1 _ |a Verschuren, W M Monique
|b 41
700 1 _ |a Zamora-Ros, Raul
|0 0000-0002-6236-6804
|b 42
700 1 _ |a Dahm, Christina C
|b 43
700 1 _ |a Perez-Cornago, Aurora
|0 0000-0002-5652-356X
|b 44
700 1 _ |a Schulze, Matthias B
|b 45
700 1 _ |a Tong, Tammy Y N
|0 0000-0002-0284-8959
|b 46
700 1 _ |a Riboli, Elio
|b 47
700 1 _ |a Wareham, Nicholas J
|0 0000-0003-1422-2993
|b 48
700 1 _ |a Danesh, John
|b 49
700 1 _ |a Butterworth, Adam S
|b 50
700 1 _ |a Forouhi, Nita G
|0 0000-0002-5041-248X
|b 51
773 _ _ |a 10.1161/JAHA.120.019814
|g p. e019814
|0 PERI:(DE-600)2653953-6
|n 23
|p e019814
|t Journal of the American Heart Association
|v 10
|y 2021
|x 2047-9980
909 C O |p VDB
|o oai:inrepo02.dkfz.de:177539
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 26
|6 P:(DE-He78)4b2dc91c9d1ac33a1c0e0777d0c1697a
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-313
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Krebsrisikofaktoren und Prävention
|x 0
914 1 _ |y 2021
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J AM HEART ASSOC : 2019
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0320
|2 StatID
|b PubMed Central
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2021-02-03
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Peer review
|d 2021-02-03
915 _ _ |a Creative Commons Attribution-NonCommercial CC BY-NC (No Version)
|0 LIC:(DE-HGF)CCBYNCNV
|2 V:(DE-HGF)
|b DOAJ
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2021-02-03
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2021-02-03
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2021-02-03
915 _ _ |a IF < 5
|0 StatID:(DE-HGF)9900
|2 StatID
|d 2021-02-03
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2021-02-03
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2021-02-03
920 1 _ |0 I:(DE-He78)C020-20160331
|k C020
|l C020 Epidemiologie von Krebs
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)C020-20160331
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21